Select your language

Suggested languages for you:
Log In Start studying!
StudySmarter - The all-in-one study app.
4.8 • +11k Ratings
More than 3 Million Downloads
Free
|
|

All-in-one learning app

  • Flashcards
  • NotesNotes
  • ExplanationsExplanations
  • Study Planner
  • Textbook solutions
Start studying

Typical and Atypical Antipsychotics

Save Save
Print Print
Edit Edit
Sign up to use all features for free. Sign up now
Typical and Atypical Antipsychotics

Drug therapies are the biological side of treatment for schizophrenia. Typical antipsychotics (also known as neuroleptics), mostly, if not entirely, address the positive symptoms of schizophrenia, such as hallucinations and paranoia. They also reduce the impact of these symptoms in general.

With the development of atypical antipsychotics, negative symptoms such as avolition can also be addressed.

Positive symptoms of schizophrenia, such as delusions, are due to the increased release of dopamine in the brain. This in turn increases the activation of dopamine 2 receptors (D2) (Brisch et al., 2014) and can result in the aforementioned positive symptoms, as dopamine acts as a modulator for many brain functions. Similarly, negative symptoms can develop when there is reduced function of dopamine receptors in the prefrontal cortex.

Psychologists classify antipsychotics into two categories: typical and atypical.

StudySmarter is not a licensed medical practitioner. The following information is for educational purposes only.

What are typical antipsychotics?

Typical antipsychotics are the first generation of drug therapies available for schizophrenia. They were developed in the 1950s, and have lost popularity since the advent of atypical antipsychotics for several reasons. Most notably due to the notion that typical antipsychotics cause more severe side effects than atypical antipsychotics.

Examples of typical antipsychotic drugs include:

  • Chlorpromazine

  • Haloperidol

  • Pimozide

  • Loxapine

They work by blocking the dopamine 2 receptor (D2), reducing the uptake of dopamine in the mesolimbic pathway (also known as the reward pathway), and can differ in potency. Positive symptoms are a result of the increased subcortical release of dopamine in the brain, possibly due to a defect in the cortical pathway through the nucleus accumbens (Brisch et al., 2014). By blocking the D2 receptors and effectively calming the dopamine system in the brain, typical antipsychotics lower the intensity of positive symptoms.

They can often be referred to as dopamine antagonists.

Typical and Atypical Antipsychotics Mesolimbic pathway schizophrenia StudySmarterOverview of reward structures in the human brain, including the mesolimbic pathway, Oscar Arias-Carrión1, Maria Stamelou, Eric Murillo-Rodríguez, Manuel Menéndez-González and Ernst Pöppel, CC-BY-3.0, Wikimedia Commons.

Haloperidol blocks around 80% of D2 receptors. Haloperidol can be injected, and is fast at acting so is often used in emergencies.

Due to the calming effect, there tends to be a general sedative effect too. Like many drugs, typical antipsychotics come with a list of unintended side effects.

Side effects of typical antipsychotic drugs

Some of the side-effects include, but are not limited to:

  • Dry mouth.

  • Constipation.

  • Low energy.

  • Sedation.

  • Tardive dyskinesia (uncontrollable muscle movements usually affecting the face).

  • Akathisia (uncomfortable restlessness).

There is no explicit evidence to state one typical antipsychotic drug is more or less effective than another. This tends to be decided by a patient’s reaction and feelings towards the effectiveness of the drug, and how they tolerate it.

What are atypical antipsychotics?

Atypical antipsychotics are considered the second generation of antipsychotic drug treatments. Developed in the 1970s, they avoid the more severe side effects of typical antipsychotics.

Examples of atypical antipsychotic drugs include:

  • Clozapine

  • Olanzapine

  • Risperidone

  • Quetiapine

They work somewhat similarly to typical antipsychotics in that they block D2 dopamine receptors in the limbic system. However, they do not affect dopamine receptors in other parts of the brain. The reduction of intensity in positive symptoms occurs as a result, but they also act on other neurotransmitters, notably:

  • Acetylcholine

  • Glutamate

  • Serotonin

They can be referred to as serotonin-dopamine antagonists.

An example is Clozapine. Clozapine binds to dopamine, serotonin, and glutamate receptors in the brain. By affecting all three neurotransmitters, atypical drugs such as Clozapine affect both positive and negative symptoms such as avolition, whilst also improving mood and cognitive functions, and reducing depression and anxiety.

Side effects of atypical antipsychotic drugs

Like typical antipsychotics, atypical antipsychotic drugs come with their list of unintended side effects:

  • Cardiovascular problems.

  • Weight gain.

  • Drowsiness.

  • Diabetes.

  • Tardive dyskinesia (uncontrollable muscle movements usually affecting the face). This is less likely to happen with atypical antipsychotics.

Although atypical antipsychotics are referred to as second-generation antipsychotics, there’s an increasing amount of research going into the efficacy of atypical antipsychotics in the treatment of schizophrenia.

Typical and Atypical Antipsychotics Antipsychotic Drugs Compared schizophrenia StudySmarterAntipsychotic drug comparison chart, Tyler Smith, StudySmarter Originals.

Are antipsychotic drug therapies effective and appropriate in treating schizophrenia?

Now that we know what typical and atypical antipsychotics are, we now must establish through evaluation whether or not they are effective and appropriate at treating schizophrenia.

Strengths:

  • Leucht et al. (2013) reviewed 212 studies, testing the effectiveness of biological antipsychotic drug treatments on how they normalise dopamine levels. 15 antipsychotic drugs were compared to their controls (placebo) in the acute treatment of schizophrenia. They were more effective than the placebos, so treatments targeting dopamine are effective in reducing symptoms.

  • Drug therapies are often cheaper than hospital treatments, therapies such as cognitive behavioural therapy (CBT), and family therapy.

  • Due to drug treatments, there are fewer long-term institutionalised patients in mental health hospitals.

  • As a result of this independence from clinical, in-house treatments, patients lead a more independent lifestyle and are in general happier and more fulfilled.

  • Schooler et al. (2005) found that, when comparing haloperidol (typical antipsychotic) to risperidone (atypical antipsychotic), low doses of antipsychotic drugs were able to significantly improve symptoms of psychosis associated with schizophrenia in first-episode patients (those early in the course of psychotic/schizophrenic illness or treatment). In the long-term, risperidone has lower rates of relapse and induces less abnormal movements (tardive dyskinesia) than haloperidol. This shows that antipsychotics are effective in treating positive and negative symptoms of schizophrenia. However, there were issues with dropouts in treatments.

  • Bagnall et al. (2003) analysed 232 studies comparing the effectiveness of atypical and typical antipsychotics. Overall, atypical antipsychotics were more effective in treating the symptoms of schizophrenia, with fewer movement disorder side effects. Fewer people also left the drug treatment early, a problem in most studies. Clozapine was the most effective at reducing negative symptoms and treating those resistant to other drugs. This suggests antipsychotics are effective treatments, especially those focused on more neurotransmitters than dopamine.

  • Crossley et al. (2010) found that, although there were no true differences between the efficacy of first and second-generation antipsychotics, second-generation were shown to cause fewer side effects in the patients.

Weaknesses:

  • Lieberman et al. (2005) compared the first-generation, typical antipsychotic drug perphenazine to a selection of second-generation, atypical drugs, such as olanzapine amongst 1,493 patients with schizophrenia. It was found that only olanzapine outperformed perphenazine in terms of discontinuation rates (where patients stop taking their medication). The rest did no better than the perphenazine.

    • Although olanzapine had superior efficacy in reducing psychopathology compared to the rest, it also had more severe side effects, such as significant weight gain.

  • Kahn et al. (2008) compared the first-generation haloperidol with second-generation antipsychotics. 498 patients were randomly assigned an antipsychotic treatment plan. Kahn found that antipsychotics were effective for at least one year, however, there was no evidence to suggest that second-generation antipsychotics were more effective than first-generation antipsychotics.

  • The amount of research indicating no true difference in the efficacy of first-generation and second-generation antipsychotics in treating schizophrenia calls into question the need to make this distinction at all.

  • The side effects of antipsychotic drugs are quite severe. Overall, two-thirds of people with schizophrenia stop taking the drugs. This creates an issue with the revolving door of treatment plans. This is where patients take their antipsychotics, find their symptoms are not being treated effectively, or are not worth the severe side effects such as tardive dyskinesia and significant weight gain, and stop taking them before eventually resuming treatment again later on.

  • This also creates issues with forced treatment. If the symptoms a patient is experiencing are severe to the point of significant distress, drugs may often be prescribed forcefully. This is an ethical issue, as informed consent is compromised, especially considering the severity of the side effects.

  • Drug therapies are also only suppressing the symptoms of schizophrenia, and not treating the root cause.

  • It is worth noting that Tarrier et al. (1998) placed patients in a combined treatment plan of antipsychotics and CBT. These patients had a significant improvement in the severity and number of their positive symptoms. So, a combination of therapies as treatments is worth considering and will be explored in the next explanations on this topic.


Typical and Atypical Antipsychotics - Key takeaways

  • Drug therapies are the biological side of treatment for schizophrenia. As they are antipsychotics, atypical antipsychotics mostly address the positive symptoms of schizophrenia, such as hallucinations and paranoia, whilst also reducing the impact of these symptoms in general. With the development of atypical antipsychotics, negative symptoms can also be addressed.
  • Typical antipsychotics are considered to be the first generation of antipsychotics and address positive symptoms by being dopamine antagonists, blocking dopamine receptors.
  • Atypical antipsychotics are the second generation of antipsychotics and address both the positive and negative symptoms of schizophrenia, by affecting dopamine, serotonin, and glutamate. They are known as serotonin-dopamine antagonists.
  • Drug therapies are effective in treating positive and negative symptoms of schizophrenia and psychosis in general. They are cheaper and offer patients more independence.
  • Both typical and atypical antipsychotics have severe side effects, although atypical less so. Both have problems with patients dropping out of treatment plans early and returning, and a lot of research is questioning whether they should be distinguished from one another.

Frequently Asked Questions about Typical and Atypical Antipsychotics

Typical and atypical antipsychotics are used to treat symptoms of schizophrenia, as a form of biological treatment.

They are a form of biological drug treatment used to help patients with their positive and negative symptoms of schizophrenia. Examples include Chlorpromazine and Haloperidol (typical antipsychotics) and Clozapine and Olanzapine (atypical antipsychotics). 

There is a belief that atypical antipsychotics are the more modern treatment plan, and have less severe side effects than typical antipsychotics. They also affect other neurotransmitters than dopamine that are linked to schizophrenic symptoms, whilst typical antipsychotics affect only dopamine. Whether or not atypical antipsychotics have less severe side effects is still up for debate.

There is no definitive ‘best antipsychotic’. However, according to a study by Oh et al. (2020) common antipsychotic drugs that show promising results are clozapine, followed by aripiprazole.

Typical antipsychotics are the first generation of antipsychotic drugs. They treat the positive symptoms of schizophrenia by blocking dopamine (D2) receptors in the brain and are known as dopamine antagonists. Atypical antipsychotics are the second generation of antipsychotic drugs and treat both positive and negative symptoms. They are known as serotonin-dopamine antagonists, as they affect multiple neurotransmitters. 

Final Typical and Atypical Antipsychotics Quiz

Question

What are drug therapies?

Show answer

Answer

Drug therapies are the biological side of treatment for schizophrenia. 

Show question

Question

What are the two types of antipsychotics?

Show answer

Answer

Typical and atypical.

Show question

Question

What are typical antipsychotics? 


Show answer

Answer

Typical antipsychotics are the first generation of drug therapies available for schizophrenia. They were developed in the 1950s, and have lost popularity since the advent of atypical antipsychotics for several reasons.

Show question

Question

How do typical antipsychotics work?

Show answer

Answer

They work by blocking the dopamine 2 receptor (D2), reducing the uptake of dopamine in the mesolimbic pathway (also known as the reward pathway), and can differ in potency. By blocking the D2 receptors and effectively calming the dopamine system in the brain, typical antipsychotics lower the intensity of positive symptoms. They can often be referred to as dopamine antagonists.

Show question

Question

What are some side effects of typical antipsychotics?

Show answer

Answer

Dry mouth, constipation, low energy, sedation, tardive dyskinesia (uncontrollable muscle movements usually affecting the face), akathisia (uncomfortable restlessness).

Show question

Question

What are atypical antipsychotics? 


Show answer

Answer

Atypical antipsychotics are considered to be the second generation of antipsychotic drug treatments. Developed in the 1970s, it was stated that they avoid the more severe side effects of typical antipsychotics.

Show question

Question

How do atypical antipsychotics work, how do they differ from typical antipsychotics?

Show answer

Answer

They work somewhat similarly to typical antipsychotics in that they block D2 dopamine receptors in the limbic system, however, they do not affect D3 receptors in other parts of the brain. The reduction of intensity in positive symptoms occurs as a result, but they also act on other neurotransmitters such as serotonin and glutamate.

Show question

Question

What are some side effects of atypical antipsychotics?

Show answer

Answer

Cardiovascular problems, weight gain, drowsiness, diabetes, tardive Dyskinesia (uncontrollable muscle movements usually affecting the face) - although, this is less likely to happen with atypical antipsychotics.

Show question

Question

What are some strengths of using drug therapies to treat schizophrenia? 


Show answer

Answer

Antipsychotics have been found to have proven efficacy in treating positive and negative symptoms of schizophrenia. They reduce institutionalised hospital treatments and encourage patient independence. Atypical antipsychotics have shown to have fewer side effects than typical antipsychotics, although both are effective at treating symptoms.

Show question

Question

What are some of the weaknesses of using drug therapies to treat schizophrenia? 

Show answer

Answer

Antipsychotics cause severe side effects in some patients, such as tardive dyskinesia, and therefore many patients stop taking their medication, creating a revolving door of treatment. They are only suppressing the symptoms of schizophrenia, not treating the root cause. There’s also not enough evidence to suggest second-generation antipsychotics are significantly better than first-generation antipsychotics, so there’s no need to separate them as such.

Show question

Question

What did Leucht et al. (2013) find in their study? 


Show answer

Answer

They found that when 15 antipsychotic drugs were compared to their controls (placebo) in the acute treatment of schizophrenia, they were more effective than their placebos, so treatments targeting dopamine are effective in reducing symptoms.

Show question

Question

What did Schooler et al. (2005) find in their study? 


Show answer

Answer

When comparing haloperidol to risperidone, low doses of antipsychotic drugs were able to significantly improve symptoms of psychosis associated with schizophrenia in first-episode patients

Show question

Question

What did Kahn et al. (2008) find in their study?

Show answer

Answer

Khan found that antipsychotics were effective for at least one year, however, there was no evidence to suggest that second-generation antipsychotics were more effective than first-generation antipsychotics.

Show question

Question

What did Tarrier et al. (1998) find in their study? 


Show answer

Answer

Combined treatment of antipsychotics and CBT seems to be the most effective treatment plan.

Show question

60%

of the users don't pass the Typical and Atypical Antipsychotics quiz! Will you pass the quiz?

Start Quiz

Discover the right content for your subjects

No need to cheat if you have everything you need to succeed! Packed into one app!

Study Plan

Be perfectly prepared on time with an individual plan.

Quizzes

Test your knowledge with gamified quizzes.

Flashcards

Create and find flashcards in record time.

Notes

Create beautiful notes faster than ever before.

Study Sets

Have all your study materials in one place.

Documents

Upload unlimited documents and save them online.

Study Analytics

Identify your study strength and weaknesses.

Weekly Goals

Set individual study goals and earn points reaching them.

Smart Reminders

Stop procrastinating with our study reminders.

Rewards

Earn points, unlock badges and level up while studying.

Magic Marker

Create flashcards in notes completely automatically.

Smart Formatting

Create the most beautiful study materials using our templates.

Just Signed up?

Yes
No, I'll do it now

Sign up to highlight and take notes. It’s 100% free.